Sign in to continue:

Tuesday, March 17th, 2026

Embassy Bancorp, Inc. 2025 Annual Report: Company Overview, Risk Factors, and Financial Data




Embassy Bancorp, Inc. 2025 Annual Report Analysis

Embassy Bancorp, Inc. (EMYB) 2025 Annual Report: Key Highlights and Investor Analysis

Overview

Embassy Bancorp, Inc., headquartered in Bethlehem, PA, has released its Annual Report (Form 10-K) for the fiscal year ending December 31, 2025. As a state commercial bank, EMYB continues to operate in the finance sector, with its primary business address at 100 Gateway Drive, Suite 100, Bethlehem, PA 18017.

Key Financial and Regulatory Highlights

  • Common Stock Outstanding: The company reported 7,563,375 shares of common stock (par value \$1.00) outstanding as of March 6, 2026. This figure is critical for valuation and per-share calculations.
  • Market Capitalization: The aggregate market value of voting and non-voting common equity held by non-affiliates was \$87,881,471 as of June 30, 2025. This is a key metric for shareholders to track company value.
  • SEC Reporting Status: Embassy Bancorp is a smaller reporting company and is not a well-known seasoned issuer. The company has met all reporting requirements for the past 90 days, which signals compliance and stability.
  • Securities Registration: The company’s common stock is registered under Section 12(g) of the Exchange Act, but no securities are registered under Section 12(b), and it is not listed on any exchange.
  • Internal Controls: The company did not require an attestation report on internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act, indicating it is exempt from this requirement as a smaller reporting company.
  • Error Corrections & Restatements: The company confirms no corrections or restatements to its financial statements that would require a recovery analysis of incentive-based compensation for executives.
  • Shell Company Status: Embassy Bancorp confirms it is not a shell company, which is important for investor confidence.
  • Proxy Statement: Portions of the definitive proxy statement for the 2026 annual meeting of shareholders are incorporated by reference into Part III of the report, indicating upcoming governance and potential director changes.

Shareholder-Relevant and Potentially Price-Sensitive Information

  • Share Repurchase Programs: The report references multiple share repurchase program axes, including purchased treasury stock (I, II, III), which could affect the number of shares outstanding and shareholder value. While the details are not explicitly provided, the existence of these programs may signal capital management initiatives that can impact share price.
  • Financial Instruments and Off-Balance Sheet Risks: Extensive disclosures are made regarding the fair value measurement of financial instruments, including commitments to extend credit, standby letters of credit, and unused lines of credit. These off-balance sheet items indicate exposure to credit risk and liquidity management, which can be material for investors.
  • Compliance & Regulatory Risks: The company’s reporting as a smaller reporting company means it is subject to less stringent regulatory requirements, which could affect risk perception and investor confidence.
  • No Securities Registered on Exchanges: The absence of exchange registration may limit liquidity and affect trading volumes, potentially impacting share price volatility.

Potential Market Movers

  • Share Repurchase Activity: If the company executes or expands share repurchase programs, this could reduce the number of outstanding shares and positively affect the share price through improved earnings per share and capital allocation.
  • Capital Adequacy & Credit Risk: The disclosures around fair value and collateral indicate active risk management. Any changes in these areas (such as significant loan impairments or increases in off-balance sheet exposure) could be price-sensitive.
  • Corporate Actions: Reference to the annual meeting and proxy statement may hint at upcoming changes in management, board composition, or governance policies—all of which can influence investor sentiment and share price.

Summary for Investors

Embassy Bancorp, Inc.’s 2025 annual report demonstrates continued compliance, stable reporting, and active risk and capital management. The key items for shareholders to monitor in the coming months include the outcome of share repurchase programs, changes in off-balance sheet risk exposure, and any corporate governance actions resulting from the 2026 annual meeting. While there are no immediate restatements or major corrections, the company’s capital and risk management actions, as well as its status as a smaller reporting company, are essential areas for investor focus.

Disclaimer

This article is based on Embassy Bancorp, Inc.’s Annual Report for the fiscal year ended December 31, 2025. The information presented is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult a licensed financial advisor before making investment decisions. Share prices may be affected by future corporate actions, regulatory changes, and market conditions.




View Embassy Bancorp, Inc. Historical chart here



Guardian Pharmacy Services Reports Strong 2025 Financial Results, Raises 2026 Adjusted EBITDA Guidance

Guardian Pharmacy Services Q4 and FY 2025 Results - In-Depth...

   Ad